Status:
COMPLETED
The Epidemiology, Process and Outcomes of Spine Oncology (EPOSO)
Lead Sponsor:
AO Foundation, AO Spine
Collaborating Sponsors:
Orthopaedic Research Foundation
Conditions:
Secondary Malignant Neoplasm of Vertebral Column
Eligibility:
All Genders
18-75 years
Brief Summary
The main purpose of this study is to utilize a comprehensive, prospective clinical database to collect patient, diagnostic and treatment variables along with disease specific and generic health relate...
Eligibility Criteria
Inclusion
- Signed informed consent
- Age between 18 and 75 years
- Able to read and write English at an elementary level
- Diagnosis of metastatic tumor of the spine
Exclusion
- The primary cancer site is central nervous system or spine
- History of substance abuse (recreational drugs, alcohol) within 12 months prior to screening
- Is a prisoner
- A disease or condition that would, in opinion of the investigator, preclude accurate evaluation (e.g. significant psychiatric disease)
Key Trial Info
Start Date :
August 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
454 Patients enrolled
Trial Details
Trial ID
NCT01825161
Start Date
August 1 2013
End Date
December 1 2019
Last Update
September 13 2022
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Kansas University Medical Center
Kansas City, Kansas, United States, 66160
2
Johns Hopkins University
Baltimore, Maryland, United States, 21218
3
Mayo Clinic
Rochester, Minnesota, United States, 55905
4
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104